Chinese herbal medicine (weijing decoction) combined with pharmacotherapy for the treatment of acute exacerbations of chronic obstructive pulmonary disease

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Liu, Shaonan ^a,b   Shergis, Johannah ^c   Chen, Xiankun ^a,b   Yu, Xuhua ^a,b   Guo, Xinfeng ^a,b   Zhang, Anthony Lin ^c   Lu, Chuanjian ^a,b   Xue, Charlie Changli ^c  

^a GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^b Guangdong Provincial Academy of Chinese Medical Sciences   (China)

^c RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMBROXOL; ANTIBIOTIC AGENT; BIOLOGICAL MARKER; BRONCHODILATING AGENT; INTERLEUKIN 8; IPRATROPIUM BROMIDE; LEVOFLOXACIN; MUCOLYTIC AGENT; PLANT MEDICINAL PRODUCT; SALBUTAMOL; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WEIJING DECOCTION;

CHINESE MEDICINE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FORCED EXPIRATORY VOLUME; HUMAN; INFORMATION RETRIEVAL; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84934948850     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/257012     Document Type: Review

References (36)

1. C. D. Mathers and D. Loncar, "Projections of global mortality and burden of disease from 2002 to 2030," PLoS Medicine, vol. 3, article e442, 2006.
2. R. J. Halbert, J. L. Natoli, A. Gano, E. Badamgarav, A. S. Buist, and D. M. Mannino, "Global burden of COPD: systematic review and meta-analysis," European Respiratory Journal, vol. 28, no. 3, pp. 523-532, 2006.
3. N. Zhong, C. Wang, W. Yao et al., "Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey," American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 8, pp. 753-760, 2007.
4. The Global Initiative for Chronic Obstructive Lung Disease (GOLD), "Global Strategy for Diagnosis Management and Prevention of COPD 2013," http://goldcopd.org.
5. Y. Zhong, B. Mao, G. Wang et al., "Tanreqing injection combined with conventional western medicine for acute exacerbations of chronic obstructive pulmonary disease: a systematic review," Journal of Alternative and Complementary Medicine, vol. 16, no. 12, pp. 1309-1319, 2010.
6. W. Liu and L. Lin, COPD & Asthma, People's Medical Publishing House, Beijing, China, 2007.
7. S. Sun, Bei Ji Qian Jin Yao Fang, Huaxia Publishing House, Beijing, China, 652.
8. Z. Wang, J. Li, M. Wang et al., "Literature study on distribution regularity of TCM syndromes of chronic obstrcutive pulmonary diseases at the acute exacerbation stage," Journal of Traditional Chinese Medicine, vol. 49, no. 8, pp. 727-730, 2008.
9. X. Jing, X. Li, and J. Liu, "Efect of modifed Qianjin Weijing decoction on nuclear factor-Kb of chronic obstructive pulmonary disease in acute stage," Chinese Journal of Integrated Traditional and Western Medicine in intensive and critical care, vol. 14, no. 5, pp. 271-274, 2007.
10. S. Li, "Clinical research of acute exacerbation of chronic obstructive pulmonary disease with modifed Weijing decoction and efect of TNF-c and IL-8 in peripheral blood," Medical information, vol. 22, no. 12, pp. 2728-2731, 2009.
11. J. Chu and Q. Ye, "Pharmacology and clinical research of Semen coicis," Journal of Liaoning University of TCM, vol. 10, no. 4, pp. 159-160, 2008.
12. H. Gao, A. Ding, and Y. Tang, "The chemical composition, pharmacological efects and the progress of clinical research of Coulis phragmitis," Research and Practice of Chinese Medicines, vol. 23, no. 3, pp. 75-78, 2009.
13. R. Wang, L. Fan, and W. Gao, "Advances in research of chemical constituents and pharmacological activities of Persicae Semen," Drugs & Clinic, vol. 25, no. 6, pp. 426-429, 2010.
14. Group of Chronic Obstructive Pulmonary Disease, Branch of Respiratory Diseases, and Chinese Medical Association, "Guidance of diagnosis and treatment of chronic obstructive pulmonary disease (reversed edition in 2007)," Zhong Hua Jie He Hu Xi Za Zhi, vol. 30, no. 1, p. 8, 2007.
15. X. Zheng, Guidance for Clinical Research on New Drugs of TCM, China Medical Science Press, 2002.
16. J. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, The Cochrane Collaboration, 2011, http://handbook.cochrane.org/.
17. H. Chen and L. Qiu, "Efect of Qianjin Weijing decoction for the treatment of 60 cases of acute exacerbations of chronic obstructive pulmonary disease," Yiyao Qianyan, vol. 2, no. 4, p. 122, 2012.
18. H. Chen, Y. Sha, and H. Chen, "Clinical observation of Weijing decoction combined with Er chen decoction for the treatment of 36 cases of acute exacerbation of chronic obstructive pulmonary disease," Chinese Journal of Coal Industry Medicine, vol. 11, no. 4, pp. 564-565, 2008.
19. X. Chen and R. Wang, "Clinical observation of treatment of 31 cases of severe chronic obstructive lung disease by clearing away heat. Resolving phlegm and activating blood circulation combined with western drugs," Jiangsu Journal of Traditional Chinese Medicine, vol. 41, no. 9, pp. 25-27, 2009.
20. Y. Guo, "Clinical research of Weijing decoction combined western medicine for the treatment of acute exacerbations of chronic obstructive pulmonary disease," Hebei Journal of Traditional Chinese Medicine, vol. 32, no. 11, pp. 1680-1681, 2010.
21. X. Jing, D. Wang, and X. Li, "Research Of Qingfeihuatan Quyu prescription on the treatment of chronic obstructive pulmonary disease in acute deteriorated stage," Chinese Journal of TCM WM Critical Care, vol. 13, no. 5, pp. 270-272, 2006.
22. J. Liu, X. Jing, and X. liu, "Infuence of modifed Qianjin Weijing Decoction on airway clearance in patient with acutely exacerbated chronic obstructive pulmonary disease," Journal of Guangzhou University of Traditional Chinese Medicine, vol. 23, no. 1, pp. 21-24, 2006.
23. J. Shi, B. Chen, and X. Wang, "Clinical observation with tonifying spleen, resolving heat and activating blood for the treatment of acute exacerbations of chronic obstructive pulmonary disease," Journal of Emergency in Traditional Chinese Medicine, vol. 19, no. 4, pp. 565-566, 2010.
24. X. Shi, L. Wu, and Z. Xu, "Treatment of 40 cases of chronical obstructive disease of lung at actue stage with Weijing Xuanbi decoction," Shandong Journal of Traditional Chinese Medicine, vol. 26, no. 2, pp. 99-201, 2007.
25. R. Xu, "Efect of integrative medicine for 78 case of acute exacerbation of chronic obstructive pulmonary disease," Strait Pharmaceutical Journal, vol. 24, no. 6, pp. 101-103, 2012.
26. M. Zang, "Clinical observation of resolving heat, phlegm and dyspnea for the Lung function of acute exacerbations of chronic obstructive pulmonary disease," Clinical Journal of Traditional Chinese Medicine, vol. 22, no. 2, pp. 137-138, 2010.
27. S. Zhan, "Clinical research of efcacy of acutely exacerbated chronic obstructive pulmonary disease (AECOPD) with modi-fed Weijing decoction," Chinese Archives of Traditional Chinese Medicine, vol. 26, no. 12, pp. 2735-2737, 2008.
28. J. Zhang, B. Du, and S. Li, "Efect of IL-8 in peripheral blood of acute exacerbations of chronic obstructive pulmonary disease treated with Weijing decoction combined with western medicine," Shanxi Journal of Traditional Chinese Medicine, vol. 30, no. 4, pp. 393-394, 2009.
29. L. Zhang, "Efect of modifed Weijing decoction for the treatment of acute exacerbations of chronic obstructive pulmonary disease," Journal of Shandong University of TCM, vol. 35, no. 2, pp. 148-149, 2011.
30. M. Cazzola, W. MacNee, F. J. Martinez et al., "Outcomes for COPD pharmacological trials: from lung function to biomark-ers," European Respiratory Journal, vol. 31, pp. 416-469, 2008.
31. L. G. Franciosi, C. P. Page, B. R. Celli et al., "Markers of disease severity in chronic obstructive pulmonary disease," Pulmonary Pharmacology & Terapeutics, vol. 19, no. 3, pp. 189-199, 2006.
32. E. F. M. Wouters, K. H. Groenewegen, M. A. Dentener, and J. H. J. Vernooy, "Systemic infammation in chronic obstructive pulmonary disease: the role of exacerbations," Proceedings of the American Toracic Society, vol. 4, no. 8, pp. 626-634, 2007.
33. W. R. Perera, J. R. Hurst, T. M. Wilkinson et al., "Infammatory changes, recovery and recurrence at COPD exacerbation," European Respiratory Journal, vol. 29, no. 3, pp. 527-534, 2007.
34. R. Wu, Z. Fengjie, Y. Li et al., "Modifed dachengqi decoction combined with conventional treatment for treating acute exacerbation of chronic obstructive pulmonary disease: a systematic review based on randomized controlled trials," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 323715, 8 pages, 2013.
35. K. R. Kendrick, S. C. Baxi, and R. M. Smith, "Usefulness of the modifed 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma," Journal of Emergency Nursing, vol. 26, no. 3, pp. 216-222, 2000.
36. K. Nishimura, T. Izumi, M. Tsukino, and T. Oga, "Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD," Chest, vol. 121, no. 5, pp. 1434-1440, 2002.